![](/img/cover-not-exists.png)
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases
Speth, Fabian, Haas, Johannes-Peter, Hinze, Claas H.Volume:
14
Language:
english
Journal:
Pediatric Rheumatology
DOI:
10.1186/s12969-016-0112-6
Date:
December, 2016
File:
PDF, 488 KB
english, 2016